Skip to main content

Table 3 Dosimetric changes in the OAR

From: Impact of adaptive intensity-modulated radiotherapy on the neutrophil-to-lymphocyte ratio in patients with nasopharyngeal carcinoma

OARs

ART+IMRT new

No.Gy

IMRT new

No.Gy

P

PG-ips

 D50

26.11 ± 6.12

27.39 ± 7.19

0.021*

 Dmean

28.68 ± 5.99

29.80 ± 7.12

0.038*

PG-con

 D50

24.69 ± 3.92

25.95 ± 4.20

0.009*

 Dmean

27.10 ± 4.01

28.02 ± 4.38

0.034*

Skin

 D50

3.03 ± 3.18

14.88 ± 6.65

< 0.001*

 Dmean

21.22 ± 22.27

18.52 ± 4.21

0.491

 Dmax

70.64 ± 5.52

71.29 ± 5.41

0.076

  1. Abbreviations: OAR organs at risk, PGs parotid glands, Dmean mean dose, D50 dose to 50% of the volume, IMRT new the new IMRT, ART+IMRT new,the new ART+IMRT
  2. *P ≤ 0.05